Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet

International Journal of Pharmaceutics

Volumn 352, Issue 1-2, 2008, Pages 225-230

  Liu, Longxiao ^a   Xu, Xiangning ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bilayer core osmotic pump tablet; Indented core tablet; Nifedipine; Orthogonal design; Similarity factor

Indexed keywords

CROSCARMELLOSE SODIUM; NIFEDIPINE; POVIDONE; SODIUM CHLORIDE;

ARTICLE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; OSMOTIC PUMP; PRIORITY JOURNAL;

CALCIUM CHANNEL BLOCKERS; CARBOXYMETHYLCELLULOSE; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; KINETICS; MEMBRANES, ARTIFICIAL; NIFEDIPINE; OSMOSIS; PERMEABILITY; POLYETHYLENE GLYCOLS; POVIDONE; SODIUM CHLORIDE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 39549106484     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.10.047     Document Type: Article

References (22)

1. Abrahamsson B., Alpsten M., Bake B., Jonsson U.E., Eriksson-Lepkowska M., and Larsson A. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J. Control. Rel. 52 (1998) 301-310
2. Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. Int. J. Pharm. 220 (2001) 77-83
3. Grundy J.S., Anderson K.E., Rogers J.A., and Foster R.T. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test. J. Control. Rel. 48 (1997) 1-8
4. Herbig S.M., Cardinal J.R., Korsmeyer R.W., and Smith K.L. Asymmetric-membrane tablet coatings for osmotic drug delivery. J. Control. Rel. 35 (1995) 127-136
5. Langer R. Drug delivery and targeting. Nature 392 (1998) 5-10
6. Li Y.Q., Rauth A.M., and Wu X.Y. Prediction of kinetics of doxorubicin release from sulfopropyl dextranion-exchange microspheres using artificial neural networks. Eur. J. Pharm. Sci. 24 (2005) 401-410
7. Liu L.X., and Che B.J. Preparation of monolithic osmotic pump system by coating the indented core. Eur. J. Pharm. Biopharm. 64 (2006) 180-184
8. Liu L.X., Ku J., Khang G., Lee B., Rhee J.M., and Lee H.B. Nifedipine controlled delivery by sandwiched osmotic tablet system. J. Control. Rel. 68 (2000) 145-156
9. Liu L.X., Khang G., Rhee J.M., and Lee H.B. Monolithic osmotic tablet system for nifedipine delivery. J. Control. Rel. 67 (2000) 309-322
10. Liu L.X., Wang J.C., and Zhu S.Y. Delivery of prazosin hydrochloride from osmotic pump system prepared by coating the core tablet with an indentation. Drug Deliv. 14 (2007) 219-224
11. Okimoto K., Miyake M., Ohnishi N., Rajewski R.A., Stella V.J., Irie T., and Uwkama K. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-β-CD. Pharm. Res. 15 (1998) 1562-1568
12. O'Rourke R.A. Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease. Am. J. Cardiol. 56 (1985) H34-H40
13. Prabakaran D., Singh P., Kanaujia P., Jaganathan K.S., Rawat A., and Vyas S.P. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int. J. Pharm. 284 (2004) 95-108
14. Rose S., and Nelson J.F. A continuous long-term injection. Austr. J. Exp. Biol. 33 (1955) 415-420
15. Santus G., and Baker R.W. Osmotic drug delivery: a review of the patent literature. J. Control. Rel. 35 (1995) 1-21
16. 2. Pharm. Res. 15 (1998) 889-896
17. Shaw, J.J., 2002. Controlled release system that needs no drilling. U.S. Patent Application 20020086054, 4 July.
18. Swanson D.R., Barclay B.L., Wong P.S., and Theeuwes F. Nifedipine gastrointestinal therapeutic system. Am. J. Med. 83 (1987) 3-9
19. Theeuwes F. Elementary osmotic pump. J. Pharm. Sci. 64 (1975) 1987-1991
20. Thombre A.G., Appel L.E., Chidlaw M.B., Daugherity P.D., Dumont F., Evans L.A.F., and Sutton S.C. Osmotic drug delivery using swellable-core technology. J. Control. Rel. 94 (2004) 75-89
21. US Pharmacopeia XXIX, 2006. US Pharmacopeial Convention, Rockville, MD, p. 1531.
22. Verma R.K., Krishna D.M., and Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Rel. 79 (2002) 7-27